Adicet Bio

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Adicet Bio and other ETFs, options, and stocks.

About ACET

Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells.

CEO

Chen Schor

CEOChen Schor

Employees

152

Employees152

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2014

Founded2014

Employees

152

Employees152

ACET Key Statistics

Market cap

53.76M

Market cap53.76M

Price-Earnings ratio

-0.50

Price-Earnings ratio-0.50

Dividend yield

—

Dividend yield—

Average volume

476.06K

Average volume476.06K

High today

$0.6525

High today$0.6525

Low today

$0.62

Low today$0.62

Open price

$0.645

Open price$0.645

Volume

476.56K

Volume476.56K

52 Week high

$1.70

52 Week high$1.70

52 Week low

$0.4471

52 Week low$0.4471

Analyst ratings

83%

of 6 ratings

Buy

83.3%

Hold

16.7%

Sell

People also own

Based on the portfolios of people who own ACET. This list is generated using Robinhood data, and it’s not a recommendation.